Search Results

Join this webcast to take a deep dive into the role of tech-enabled healthcare in employer-sponsored plans.

The intersection of rising costs, the hybrid workplace, and heightened employee expectations is reshaping the way employers think about health care benefits; but this presents an opportunity for brokers to get creative with what they offer their clients.

David A. Saltzman sits down with Susan Thomas, Chief Commercial Officer at LucyRx, to dive into the challenges and innovations in the PBM industry.

If we can play at being race care drivers and airplane pilots, why not take a turn as the nervous stewards of dwindling pots of premium dollars?

Matthew Fiedler wants policymakers to pay more attention to the drug manufacturers.

The average percentage of assets compared to total liabilities has held steady in the 71% to 79% range over the past five years, according to the National Conference of Public Employee Retirement Systems.

While rising costs are concerning, there’s good news -- 84% of employers’ health plan spend is tied to areas can be managed strategically to reduce costs without compromising care.

Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit by the U.S. Department of Health and Human Services Office of Inspector General found.